Menu

Driving Change in UK Lung Cancer

The UK Lung Cancer Coalition (UKLCC) is calling for a doubling
of five-year lung cancer survival rates to 25% by 2025.

Whether you are a health professional working in the forefront
of lung cancer, a patient group, policy maker, health organisation
or member of the public, help us improve outcomes for people living
with lung cancer in the UK.

Join us…

Who we are

Who
we
are

Our reports

Read our reports

Read our news & blogs

Read our news & blogs

Lung cancer facts

Lung cancer facts

5 days ago
RT @BTOGORG: The programme for #BTOG21 is now available on our website https://t.co/l9FgZ1NGHH @DrSanjayPopat @tnewsomdavis https://t.co/LK…
7
7 days ago
RT @Roy_Castle_Lung: If you or someone you care for are living with lung cancer, the thought of shielding ending may spark some anxiety. He…
6
12 days ago
RT @LungConsultant: Well conducted IPD meta-analysis (n=2394) of pleural recurrence after transthoracic needle biopsy in stage 1 lung cance…
25
20 days ago
RT @mariecurieuk: Today we're inviting you to come together to reflect on our collective loss, support those who’ve been bereaved, and hope…
1.4K
20 days ago
RT @HJA_Asbestos: Some key finding from @RCP_NLCA annual report of #lungcancer diagnoses in 2018: Late-stage diagnoses havereduced to 49%…
2
20 days ago
RT @CCM2021: Save the Date: 14-16 April ‘21 The ‘Virtual’ Cambridge Chest Meeting (in partnership with the British Institute of Radiology (…
6

Quick Links

Contact

UKLCC Secretariat: Red Hot Irons Ltd, Miria House, 1683b, High St, Knowle, Solihull, B93 0LL

Tel: 01675 477605
Email: info@uklcc.org.uk
Media enquiries only: Call 07778 304233

Legal Notices | Privacy Policy
 | Articles of Association | Memorandum of Association

The UKLCC is a private company limited by guarantee without share capital and incorporated as a Community Interest Company (CIC) registered at Companies House (Registration Number 11914752) and operating throughout the United Kingdom

✕

COVID-19 Information

Lung cancer and mesothelioma service guidance during the COVID-19 pandemic

Read ...

✕

New Report: COVID-19 Matters

A review of the impact of COVID-19 on the lung cancer pathway and opportunities for innovation emerging from the health system response to the pandemic
Read ...

✕

COVID-19 Matters Report

READ OUR NEW REPORT: COVID-19 Matters - a review of the impact of COVID-19 on the lung cancer pathway and opportunities for innovation emerging from the health system response to the pandemic

Read report...

✕

Virtual Consultations Report

Read our blog on new report endorsed by UKLCC providing patient and clinical insights into use of virtual consultations in response to COVID-19.

Read report...